Sight Sciences has launched the Ergo-Series of the OMNI Surgical System in the US, which is specifically designed to help surgeons in performing minimally invasive, implant-free glaucoma procedures in adults suffering from primary open-angle glaucoma.
The OMNI Surgical System facilitates a minimally invasive glaucoma surgery (MIGS) that targets all three known points of resistance in the aqueous outflow system, including the trabecular meshwork, Schlemm's canal, and the collector channels. This technology can be used before, in combination with, or after cataract surgery.
The new features of the Ergo-Series include:
● Improved Handle Ergonomics: New enhancements enable surgeons to more easily rotate and position the cannula tip within Schlemm’s canal with precise finger rotations versus wrist adjustments
● Simplified Viscoelastic Preparation: The handle’s viscoelastic luer connector is now removable and detaches when the viscoelastic cartridge is removed, resulting in more clearance with the surgical microscope
● New Cannula Tip Design: The Ergo-Series cannula tip has a new profile that enables gentle and precise access to Schlemm's canal while continuing to enable full 360-degree catheterization associated with the OMNI procedure
"The Ergo-Series maintains the same therapeutic functionality as the second-generation OMNI Surgical System. The technology enhancements provide additional benefits that enable surgeons to perform an innovative, minimally invasive glaucoma surgery," Reay Brown, MD, a glaucoma specialist and Sight Science's Chief Medical Officer, said in a company news release.
“For me, the new cannula tip technology is the biggest improvement,” said Zarmeena Vendal, MD, glaucoma surgeon and founder of Westlake Eye Specialists in Austin, Texas. “The profile of the tip enables me to score the trabecular meshwork more confidently and makes entry into Schlemm’s canal gentler. In addition, when I deploy the catheter, I can follow the path of the Schlemm’s canal a bit more naturally. In our glaucoma surgery practice, access to the OMNI Surgical System lets us provide these new technology procedures for the benefit of our patients.”
The OMNI Surgical System's indications for use, contraindications, warnings, and precautions remain unchanged. It is used for treating primary open-angle glaucoma in adults by canaloplasty and trabeculotomy, and can be used before, with, or after cataract surgery.
The Ergo-Series of the OMNI Surgical System will be available outside the United States later this year.